Cancer Cytopathology 2002: Vol 96 Index

7 Pages·2002·1.3 MB·English

Subject Index—Volume 96
No. 1, February 25, pp. 1-58 No. 4, August 25, pp. 195-258
No. 2, April 25, pp. 59-124 No. 5, October 25, pp 259-318
No. 3, June 25, pp. 125-194 No. 6, December 25, 319-386
A C
Adult T-cell leukemia/lymphoma, cytology, immunohis- Ca 15-3, in hepatic tumors, 53
tochemistry, and flow cytometry of, 110 Cancer Cytopathology, online publication of, 59
AE1/AE3 multicytokeratin, in ductal lavage fluid, immu- CD56-positive natural killer/T-cell lymphoma, fine-nee-
nocytochemical analysis of, 244 dle aspiration cytology of, 344
Angioimmunoblastic T-cell lymphoma, cytology of, 166 CD68 macrophages, in ductal lavage fluid, immunocyto-
Arthritis, rheumatoid, fine-needle aspiration cytology of, chemical analysis of, 244
157 Cervical adenocarcinoma
Articular/periarticular lesions, fine-needle aspiration cy- invasive, diagnostic sensitivity for, 5
tology of, 157 ThinPrep vs. conventional cytology for, 338
Ascitic fluid, in ovarian cancer, BAGE, GAGE, and MAGE Cervical adenocarcinoma in situ, cervical smear in, sen-
sitivity of, 319 (editorial), 330
in, 187
Atypical glandular cells of undetermined significance, in Cervical cytology. See also Papanicolaou smear; ThinPrep
cervical smears
conventional vs. ThinPrep smears, |
Atypical squamous cells of undetermined significance, in in adenocarcinoma in situ, sensitivity of, 319 (edito-
rial), 330
cervical cytology
atypical glandular cells of undetermined significance
diagnostic utility of, 125 (editorial), 128
in, in conventional vs. ThinPrep smears, |
HPV DNA testing for, 14
atypical squamous cells of undetermined significance
3-D microscopic evaluation of, 181
in
diagnostic utility of, 125 (editorial), 128
B
HPV DNA testing for, 14
BAGE, in ascitic fluid in ovarian cancer, 187 3-D microscopic evaluation of, 181
Benign endometrial glandular cells, in cervical smears, benign endometrial glandular cells in, from postmeno-
from postmenopausal women, 60 pausal women, 60
Biopsy. See also Fine-needle aspiration biopsy/cytology depot medroxyprogesterone acetate effects on, 74
sentinel node, intraoperative, with rapid imprint cytol- interobserver variability in, 67
ogy, 150, 225 in invasive adenocarcinoma diagnostic sensitivity of, 5
Bladder neoplasms postmenopausal vs. Depo-Provera-related changes in,
urine cytology for 74
DNA image cytometry in, 374 in postmenopausal women, 60, 195
fluorescence in situ hybridization in, 374 sensitivity of, measurement of, 210
WHO/ISUP classification system for, 140 in severe dysplasia, 210
WHO/ISUP classification system for, 140 Triphasal and, 74
Breast Cervical dysplasia, severe, cytology of, 210
fine-needle aspiration cytology of, in males, 101 Cervical transitional cell metaplasia, HPV infection and,
papillary neoplasms of, cytologic features of, 92 250
Chondromatosis, synovial, fine-needle aspiration cytol-
Breast cancer
ogy of, 157
fine-needle aspiration biopsy of, tumor cell enrichment
Colon cancer, liver metastases in, Das-1 monoclonal an-
in, 275
tibody in, 370
intraoperative sentinel node biopsy in, with rapid im-
Cyst, ganglion, fine-needle aspiration cytology of, 157
print cytology, 150, 225
invasive ductal, aggressive subtype of, 294
D
mucinous, micropapillary variant of, 280
Breast cells, in ductal lavage fluid, immunocytochemical Das-1 monoclonal antibody, in liver fine-needle aspirate,
analysis of, 244 370
382 CANCER (Cancer CytopatHotocy) December 25, 2002 / Volume 96 / Number 6
Depot medroxyprogesterone acetate, cervical cytology Hepatic adenocarcinoma, vs. hepatocellular carcinoma,
and, 74 Glut-1 vs. CA 15-3 in, 53
Dermatofibrosarcoma protuberans, cytology of, 351] Hepatic metastases
Desmoplastic small round cell tumor, cytology of, 21 from colon cancer, Das-1 monoclonal antibody from,
DNA image cytometry, in urine cytology, 374 370
DNA testing, for human papillomavirus, for equivocal Hep Parl antibody in, 49
cervical cytology, 14 Hepatobiliary cystadenoma with mesenchymal stroma,
Ductal lavage fluid, breast cells in, immunocytochemical fine-needle aspiration cytology of, 37
analysis of, 244 Hepatoblastoma, cytomorphologic features of, in serous
effusions, 267
E Hepatocellular carcinoma
Effusion cytology, thyroid transcription factor-1 in, 43 vs. adenocarcinoma, Glut-1] vs. CA 15-3 in, 53
Endometrial cancer, abnormal peritoneal washings in, DNA fragmentation and cell proliferation in, grade and,
after hysteroscopy, 123 301
Endometrial glandular cells, benign, in cervical smears, Hep Parl antibody in, 49
from postmenopausal women, 60 HepParl antibody, in hepatic tumors, 49
Endoscopic ultrasound-guided fine-needle aspiration bi- Histioid cells, in papillary thyroid cancer, 240
opsy Human papillomavirus, DNA testing for, for equivocal
gastrointestinal/mediastinal, 232 cervical cytology, 14
pancreatic, 232, 362 human papillomavirus infection, cervical transitional cell
metaplasia and, 250
F Hiirthle cell carcinoma, cytologic criteria for, 259 (edito-
rial), 261
Fine-needle aspiration biopsy/cytology
Hysteroscopy, in endometrial cancer, positive peritoneal
of angioimmunoblastic T-cell lymphoma, 166
washings after, 123
of articular and periarticular lesions, 157
of CD56-positive natural killer/T-cell soft tissue lym-
I
phoma, 344
of dermatofibrosarcoma protuberans, 35] Imprint cytology
endoscopic ultrasound-guided, 174 in intraoperative sentinel node biopsy, in breast can-
gastrointestinal/mediastinal, 174, 362 cer, 150, 225
pancreatic, 174, 362 of sclerosing hemangioma, 146
of hepatobiliary cystadenoma_ with mesenchymal Intraductal papilloma, of breast, vs. papillary carcinoma,
stroma, 37 92
of hepatocellular carcinoma, DNA fragmentation and
cell proliferation in, 301 J
of Hiirthle cell carcinoma, 259 (editorial), 261 Joint lesions, fine-needle aspiration cytology of, 157
of liver, Das-1 monoclonal antibody in, 370
of male breast, 101
of papillary thyroid cancer, histioid cells in, 240
Lavage fluid, breast cells in, immunocytochemical anal-
tumor cell enrichment in, in breast cancer, 275
ysis of, 244
Flow cytometry, of adult T-cell leukemia/lymphoma, 110
Letters to editor, 123
Fluorescence in situ hybridization, in urine cytology, 374
Leukemia, adult T-cell, cytology, immunohistochemistry,
Fluorescence in situ hybridization-based assay, for lung
and flow cytometry of, 110
cancer cells in bronchial washings, 306
Levonorgestrel—ethinyl estradiol, cervical cytology and,
74
G
Liver. See also under Hepatic
GAGE, in ascitic fluid in ovarian cancer, 187 adenocarcinoma of, vs. hepatocellular carcinoma,
Ganglion cysts, fine-needle aspiration cytology of, 157 Glut-1 vs. CA 15-3 in, 53
Gastrointestinal masses, endoscopic ultrasound-guided metastases to
fine-needle aspiration biopsy of, 232, 362 from colon cancer, Das-1 monoclonal antibody
Glandular cell abnormality, on cervical smears, from from, 370
postmenopausal women, 60 Hep Parl antibody in, 49
Glut-1, in hepatic tumors, 53 Lung, sclerosing hemangioma of, imprint cytologic fea-
Gout, fine-needle aspiration cytology of, 157 tures of, 146
Lung cancer
H
bronchial washings from, fluorescence in situ hybrid-
Hemangioma, pulmonary sclerosing, imprint cytologic ization-based assay of, 306
features of, 146 thyroid transcription factor 1 in, 289
Subject Index—Volume 96 383
thyroid transcription factor-1 in, 43 diagnostic utility of, 125 (editorial), 128
Lymph node biopsy, sentinel node, intraoperative, with HPV DNA testing for, 14
rapid imprint cytology, 150, 225 3-D microscopic evaluation of, 181
Lymphoma conventional vs. ThinPrep smears, interobserver vari-
adult T-cell, cytology, immunohistochemistry, and ability in, 67
flow cytometry of, 110 from postmenopausal women
angioimmunoblastic T-cell, cytology of, 166 benign endometrial glandular cells in, 60
CD56-positive natural killer/T-cell, fine-needle aspira- increasing yield from, 195
tion cytology of, 344 sensitivity of
for invasive adenocarcinoma, 5
M
measurement of, 210
MAGE, in ascitic fluid in ovarian cancer, 187 in severe dysplasia, 210
Malignant mesothelioma, Wilms tumor susceptibility ThinPrep. See ThinPrep cervical smears
gene 1 in, 105 Papillary thyroid cancer, histioid cells in, 240
Mammary epithelial/foam cells, in ductal lavage fluid, Pelvic washings
immunocytochemical analysis of, 244 micropapillary serous carcinoma of ovary in, 135
Mammary mucinous carcinoma, micropapillary variant in ovarian cancer, BAGE, GAGE, and MAGE in, 187
of, 280 Periarticular lesions, fine-needle aspiration cytology
Mediastinal masses, endoscopic ultrasound-guided fine- 157
needle aspiration biopsy of, 232 Peritoneal washings
Medroxyprogesterone acetate, depot, cervical cytology micropapillary serous carcinoma of ovary in, 135
and, 74 in ovarian cancer, BAGE, GAGE, and MAGE in, 187
Mesothelioma, Wilms tumor susceptibility gene 1 in, 105 positive, in endometrial cancer, after hysteroscopy, 123
Metastases, hepatic Pigmented villonodular synovitis, fine-needle aspiration
from colon cancer, Das-1 monoclonal antibody in, 370 cytology of, 157
Hep Parl antibody in, 49 Postmenopausal women
Micropapillary serous carcinoma of ovary, in peritoneal/ benign endometrial glandular cells in cervical smears
pelvic washings, 135 from, 60
Monoclonal antibody Das-1, in liver fine-needle aspirate, cervical screening yield in, 60
370 Pulmonary sclerosing hemangioma, imprint cytologic
Mucinous breast cancer, micropapillary variant of, 280 features of, 146
Musculoskeletal sarcoma, histopathologic and cytologic
grading concordance for, 83 Q
Myoepithelial salivary gland carcinoma, cytology of, 32 Quality control, 100% thorough rescreening of ThinPrep
smears in, 325
N
Natural killer cell lymphoma, CD56-positive, fine-needle R
aspiration cytology of, 344
Rapid imprint cytology. See Imprint cytology
Nephrogenic adenoma, DNA profiles and numeric histo-
Rheumatoid arthritis, fine-needle aspiration cytology of,
gram Classifiers in, 117
157
O
S
Online publication, of Cancer Cytopathology, 59
Ovarian cancer Salivary gland carcinoma, myoepithelial, cytology of, 32
ascitic fluid in, BAGE, GAGE, and MAGE in, 187 Sarcoma
micropapillary serous, in peritoneal/pelvic washings, musculoskeletal, histopathologic and cytologic grading
135 concordance for, 83
synovial, fine-needle aspiration cytology of, 157
2 Sclerosing hemangioma, pulmonary, imprint cytologic
Pancreas, endoscopic ultrasound-guided fine-needle as- features of, 146
piration biopsy of, 232 Sentinel node biopsy, intraoperative, with rapid imprint
Papanicolaou smears. See also Cervical cytology; Thin- cytology, 150, 225
Prep cervical smears Serous effusions, in hepatoblastoma, cytomorphologic
in adenocarcinoma in situ, sensitivity of, 319 (editori- features of, 267
al), 330 Soft-tissue lymphoma, CD56-positive natural killer/T-
atypical glandular cells of undetermined significance cell, fine-needle aspiration cytology of, 344
in, vs. in ThinPrep smears, 1] Soft-tissue sarcoma, histopathologic and cytologic grad-
atypical squamous cells of undetermined significance ing concordance for, 83
in Spindle cell sarcoma, cytology of, 351
384 CANCER (Cancer CytopatHotocy) December 25, 2002 / Volume 96 / Number 6
Synovial chondromatosis, fine-needle aspiration cytology papillary, histioid cells in, 240
of, 157 Thyroid transcription factor-1
Synovial sarcoma, fine-needle aspiration cytology of, 157 in effusion cytology, 43
in lung cancer, 43, 289
z. Touch imprint. See Imprint cytology
T-cell lymphoma Tumor cell enrichment, in fine-needle aspiration biopsy,
angioimmunoblastic, cytology of, 166 of breast, 275
CD56-positive, fine-needle aspiration cytology of, 344
U
rhinPrep cervical smears. See also Cervical cytology
100% thorough rescreening of, 325 Ultrasound-guided fine-needle aspiration biopsy, endo-
atypical glandular cells of undetermined significance scopic, 174
in, vs. in conventional smears, 1 gastrointestinal/mediastinal, 232, 362
atypical squamous cells of undetermined significance pancreatic, 232, 362
in, HPV DNA testing for, 14 Urine cytology
cell blocks from, diagnostic value, feasibility, and va- DNA image cytometry in, 374
lidity of, 204 fluorescence in situ hybridization in, 374
vs. conventional smears, interobserver variability in, 67 WHO/ISUP classification system for, 140
ThinPrep slides, for desmoplastic small round cell tumor,
WwW
21
Three-dimensional microscopy, of cervical atypical squa- Wilms tumor susceptibility gene 1, in malignant me-
mous cells of undetermined significance, 181 sothelioma, 105
Thyroid, follicular lesions of, misclassification of, 323 World Health Organization/International Society of Uro-
Thyroid cancer logic Pathologists classification system, for blad-
follicular, misclassification of, 323 der neoplasms, 140
Authors’ Index—Volume 96
A Delgado, P. I., 289 Hoshino, H., 146
Dillner, J., 14 Huh, J., 344
Abati, A., 110
Dodd, L. G., 157 Hunt, K., 225
Adegboyega, P. A., 37
Domanski, H. A., 351 Hynan, L., 338
Ah, S; Z., 135, 267
Doolin, E., 181
Alli, P. M., 135
I
Allpress, S., 5, 330
E Ip, P., 166
Ashfaq, R., 49, 338
Edmundowicz, S., 362 Iyoda, A., 146
Elgert, P. A., 67
B
Eloubeidi, M. A., 232 J
Baba, M., 146 Eltoum, I., 232
Barnes, E., 110 Ernst, L. M., 275 Jacobson, K., 306
Bell, D. A., 60 Jhala, D., 232
Bentz, J. S., 325 F Jhala, N., 232
Bibbo, M., 53, 370 Jhala, N. C., 67
Fernandez-Llamazares, J., 150
Birner, P., 117 Jobse, C., 101
Filie, A. C., 323
Bloom, L. I., 74 Jones, C., 83
Frable, W. J., 59, 128
Bonfiglio, T. A., 125 Jorda, M., 289
Fraile, M., 150
Breitenecker, G., 117 Julian, F. J., 150
Frost, F. A., 330
Brogi, E., 60
Fujisawa, T., 146
Bubendorf, L., 306, 374 K
Fusté, F., 150
Bui, M., 294 Kalogeraki, A., 301
3urke, M., 53 G Kang, Y.-K., 344
Burke, M. A., 370 Kaptain, S., 74
Gaiser, M., 218
Buschmann, B., 92 Kasal, K., 362
Ganjei-Azar, P., 289
Keyhani-Rofagha, S., 204
Garbagnati, F., 301
C
Gatscha, R. M., 67
Cardillo, M., 21 Gokaslan, S. T., 49 Khang, S. K., 344
Castella, E., 150 Gomez-Fernandez King, B. L., 244
Catalano, E., 181 Gong, G., 344 Kiviat, N. B., 14
Chen, V. K., 232 Gourgiotis, L., 323 Kleiber, B., 374
Cheung, F. M. F., 2¢ Greenberg, G., 181 Klipfel, N., 83
Cheung, L. K. N., 2° Grilli, B., 306, 374 Krishnamurthy, S., 225
Chhieng, D. C., 32, 67, Gustafson, P., 351 Kurman, R. J., 14
Cho, E. Y., 344
Chow, J. C. Y., 43, 250 H L
Choy, C., 166 Haffty, B. G., 244 Lahoti, S., 174
Cibas, E. S., 128 Hagmar, B., 14 Layfield, L. J., 83
Clarke, A., 195 Hakh, N., 195 Lee, A., 225
Colgan, T. J., 195 Halling, K., 306 Lee, B. H., 105
Collins, R. J., 166 Heeht, J. L., I, 305 Lee, K. R; 1
Crapanzano, J. P., 21 Herzog, M., 374 Legator, M., 306
Crisi, G. M., 244 Heslin, M. J., 232 Li, A. S. M., 250
Curry, J. L., 140 Hewitt, C. W., 181 Lightfoot, S., 218
Cuzick, J., 14 Hijazi, Y., 110 Lin, O., 21
Hiroshima, K., 146 Liu, K., 83
D Hirschowitz, S., 83 Llatjés, M., 150
Dahmoush, L., 110 Hjerpe, A., 14 Logrono, R., 37
Dalquen, P., 306, 374 Hofmann, M., 187 Lu, D., 294
Das, K. M., 370 Horiuchi, F., 146 Lu, D. W., 362
386 CANCER (Cancer CytopatHotocy) December 25, 2002 / Volume 96 / Number 6
M Remkes, G. W., 117 Stetler-Stevenson, M., 110
Maddox, P., 14 Renshaw, A. A., 128, 210, 240, 261 Stoler, M. H., 14
Major, N. M., 157 Rimm, D. L., 244, 275 Susani, M., 117
Manos, M. M., 14 Roberson, J., 67 Symmans, W. F., 225
Marshall, C. J., 325 Rovira, C., 150
Masood, S., 294 Rowe, L. R., 325 T
Michael, C. W., 92 Rull, M., 150 Talley, L. I., 67
Miranda, A., 330 Ruschenburg, I., 187 Tambouret, R., 60
Morrison, L., 306 S Tamm, M., 306
Tani, E., 259
N
Saboorian, M. H., 49, 338 Tsai, S. C., 244
Ne, PK H.43 Sahin, A., 225
Ng, W. K., 43 Saitoh, H., 146 V
Ng, W.-k., 166 Santinami, M., 301
Vesey-Shecket, M., 204
Ng, W.-K., 250, 280 Sarlis, N. J., 323
Vickers, S., 232
Nomoto, Y., 146 Schatzl, G., 117
Schiffman, M., 14 W
O
Schoolland, M., 5, 330
Oberholzer, M., 374 Schorge, J. O., 338 Walsh, D., 362
O'Hare, A., 306 Scott, D. R., 14 Weir, E. G., 267
Ohwada, H., 146 Seelig, S., 306 Weir, M. M., 74
Segal, A., 330 Westenend, P. J., 101
P
Seidenfeld, A., 195 Wiener, H. G., 117
Padilla, L. A., 319 Sheets, E. E., 1 Wilcox, C. M., 232
Paulino, A. F., 32 Sherman, M. E., 14 Wojcik, E. M., 140
Phillips, R. F., 244 Shibuya, K., 146
Pinkus, G. S., 105 Shin, H. J. C., 174 Y
Pinkus, J. L., 105 Siddiqui, M. T., 49 Ylagan, L. R., 362
Pitman, M. B., 128 Sienko, A., 218 Young, N. A., 53, 370
Powers, C. N., 128 Skoog, L., 259
Pycha, A., 117 Smith, H. O., 319 Z
R Sneige, N., 174, 225 Zakowski, M. F., 21
Sokolova, I. A., 306 Zimmerman, R. L., 53, 37
Rampy, B. A., 37 Solomides, C. C., 53, Zoras, O., 301
Ramsamooj, R., 18] Sterrett, G. F., 5, 330 Zuna, R. E., 218